Clinical Trials Logo
  1. Home
  2. Sjogren's Syndrome
  3. NCT05946941

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome — POETYK SjS-1  

Sjögren's Syndrome Clinical Trial

Official title:
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05946941
Study type Interventional
Source Bristol-Myers Squibb
Contact BMS Study Connect Contact Center www.BMSStudyConnect.com
Phone 855-907-3286
Email Clinical.Trials@bms.com
Status Recruiting
Phase Phase 3
Start date September 11, 2023
Completion date November 16, 2028
View Details
See also
  Status Clinical Trial Phase
Completed NCT05633524 - HRR as a Novel Biomarker in Sjögren's Syndrome
Terminated NCT02843659 - Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome Phase 2
Completed NCT04129164 - A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome Phase 2
Completed NCT04798911 - SS-INQ Information Needs Questionnaire in Sjögren's Syndrome
Recruiting NCT05605665 - Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome Phase 1/Phase 2
Completed NCT02833311 - e-Mobile Tablet for People With Chronic Conditions N/A
Completed NCT04572841 - Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) Phase 2
Completed NCT04111341 - A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome. Phase 2
Recruiting NCT03060005 - Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ? N/A
Terminated NCT01316770 - Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects Phase 2
Completed NCT02422407 - A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome N/A
Completed NCT01160666 - Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome Phase 2
Active, not recruiting NCT02849093 - Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome. N/A
Active, not recruiting NCT02112019 - Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome N/A
Recruiting NCT03983408 - Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease N/A
Completed NCT00873496 - Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients N/A
Completed NCT05680064 - The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome N/A
Recruiting NCT02855658 - Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome Phase 2
Recruiting NCT02110446 - Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome Phase 2
Recruiting NCT03434106 - Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction N/A